Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4ES
|
||||
Former ID |
DIB008184
|
||||
Drug Name |
Atamestane-plus- Toremifene
|
||||
Synonyms |
Atamestane-plus-toremifene
|
||||
Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Phase 3 | [521531] | ||
Company |
Intarcia Therapeutics
|
||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Modulator | [529105] | |
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | Endogenous sterols | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.